Urine proteomics to detect biomarkers for chronic allograft dysfunction

Area of Science:

• Nephrology
• Proteomics
• Transplant Immunology

Background:

• Kidney transplant failure due to chronic allograft dysfunction affects over 50% of recipients despite optimal immunosuppression.
• Early diagnosis of chronic allograft dysfunction is crucial for timely intervention and extending graft survival.

Purpose of the Study:

• To investigate urinary polypeptide patterns for noninvasive diagnosis of chronic allograft dysfunction.
• To differentiate between specific histologic lesions: pure interstitial fibrosis and tubular atrophy (IFTA) and chronic active antibody-mediated rejection (cAMR).

Main Methods:

• Mass spectrometry was used to analyze urinary polypeptide profiles.
• Unsupervised hierarchical clustering was applied to segregate samples based on clinical conditions.
• A validation set was used to confirm the discriminatory protein ions.

Main Results:

• Urinary proteome patterns effectively segregated patients into four groups: IFTA, cAMR, stable recipients, and healthy controls.
• Distinct proteomic differences were observed between IFTA and cAMR groups.
• A panel of 14 protein ions accurately identified 100% of patients in both the IFTA and cAMR groups.

Conclusions:

• Urinary polypeptide profiling can distinguish between major histologic lesions in chronic kidney transplant dysfunction.
• This approach represents a significant first step towards developing a noninvasive diagnostic tool for chronic allograft dysfunction.
• Identifying specific proteomic signatures may enable targeted therapies and improve long-term kidney transplant outcomes.